【摘要】 目的 :探讨氧驱动雾化吸入对流行性喘憋性肺炎的临床效果。方法 :两组均在抗感染、止咳、平喘、强心、镇静、应用激素、吸氧等综合治疗的基础上进行 ,治疗组氧驱动雾化吸入 (0 .5 % )沙丁胺醇及 (0 .0 2 5 % )异丙托品 ,对照组超声雾化吸入庆大霉素、α -糜蛋白酶、氟美松。结果 :治疗组显效 30例 ,有效 9例 ,无效 1例 ,对照组显效 15例 ,有效 17例 ,无效 8例 ,治疗组显著高于对照组 ,无效率明显低于对照组 ,经卡方检验 χ2 =2 0 .4 6 ,P <0 .0 1,差别有显著性。结论 :应用 0 .5 %沙丁胺醇及 0 .0 2 5 %异丙托品氧驱动雾化吸入治疗流行性喘憋性肺炎起效快、疗效高、使用方便 ,无明显毒副作用 ,值得临床推广应用。更多还原

【Abstract】 Objective:To observe the clinical therapeutic effect of aspirating oxygen nebulization for the epidemic asthmatic pneumonia. Methods: A total of 80 patients were designed in the test group and the control group in each 40 cases. While the two group were treated by expectant therapy, the test group was inhaled the Albuterol (0.5%) and ipratropium bromide (0.025%) by the way of Oxygen Nebulization; the control group was inhaled the mist of gentamycin, theα-chymotrypsin and the dexamethasone the method of Ultrasonis Nebulization. Results: The effectual cases, effective cases, ineffective case were 30, 9,1 and 15, 17, 8 respectively in the test and the control group (χ 2=20.46,P<0.01). Conclusions: The epidemic gasping pneumonia can be fast, effectively treated giving the Albuterol (0.5%) and ipratropium bromide (0.025%) by Oxygen Nebulization Aspiration and no side effect is found. It can be widely and conveniently applied to clinic.更多还原